The CRO concept sector declined in the short term, with Lingkang Pharmaceutical, Zhaoyan New Pharmaceutical, and Minovar falling to a standstill, while Wanbang Pharmaceutical, Baihua Pharmaceutical, Yiyi Pharmaceutical, and Shuangcheng Pharmaceutical followed suit.

Zhitongcaijing · 2d ago
The CRO concept sector declined in the short term, with Lingkang Pharmaceutical, Zhaoyan New Pharmaceutical, and Minovar falling to a standstill, while Wanbang Pharmaceutical, Baihua Pharmaceutical, Yiyi Pharmaceutical, and Shuangcheng Pharmaceutical followed suit.